Article
Short-term pregnancy outcomes and drug interactions after simultaneous exposure to Nematavir/Ritonavir (Paxlovid) and immunosuppressants in pregnant women
2024-05-03
Abstract excerpt
<title>Abstract</title> <p><bold>Background </bold>In the context of the coronavirus disease 2019 (COVID-19) pandemic, pregnant women, especially those who have been receiving long-term immunosuppressive therapy, are considered at high risk for developing severe COVID-19. However, there are limited available data regarding the safety of Paxlovid for the treatment of novel coronavirus infection during pregnancy. M...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93efa2fa-b33d-53b6-bb89-02c670eeee10
- DOI
- 10.21203/rs.3.rs-4304861/v1
